scholarly journals Inguinal lymph node presenting as the delayed site of metastasis in early stage endometrial carcinoma: Case report

2017 ◽  
Vol 32 ◽  
pp. 12-15 ◽  
Author(s):  
Shomaila Amir M. Akbar ◽  
Mutahir A. Tunio ◽  
Wafa AlShakweer ◽  
AbdulAziz AlObaid ◽  
Mushabbab AlAsiri
2021 ◽  
pp. 100769
Author(s):  
Dib Sassine ◽  
Sara Moufarrij ◽  
Anjelica Hodgson ◽  
Sarah Ehmann ◽  
Nadeem R. Abu-Rustum ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6 ◽  
Author(s):  
Dogan Vatansever ◽  
Hamdullah Sozen ◽  
Gulcin Sahin Ersoy ◽  
Burak Giray ◽  
Samet Topuz ◽  
...  

Purpose. We aimed to investigate whether systematic pelvic and paraaortic lymph node dissection delivers any survival advantage in a subgroup of patients with type II endometrial carcinoma and carcinosarcoma. Methods. We evaluated 135 patients with clinically early-stage (Stage I-II) type II endometrial carcinoma and carcinosarcoma who underwent systematic pelvic and paraaortic lymph node dissection or who did not undergo any lymph node dissection. Results. Overall survival (OS) and recurrence-free survivals (RFS) were significantly longer in the systematic lymph node dissection group (hazard ratio 0.28, 95% CI 0.13–0.62 p=0.002 for OS and hazard ratio 0.31, 95% CI 0.14–0.69 p=0.004 for RFS). Multivariate analysis showed that lymph node dissection, age, lymph node metastasis, and adjuvant therapy were independent prognostic variables of OS and RFS. Conclusions. Systematic pelvic and paraaortic lymph node dissection independently and significantly prolongs the survival of patients with early-stage type II endometrial carcinoma and carcinosarcoma.


2015 ◽  
Vol 28 (2) ◽  
pp. e55-e56
Author(s):  
Janie Benoit ◽  
Andrew Trout ◽  
Myron Allukian ◽  
Beth Schwartz

2019 ◽  
Vol 6 (1) ◽  
pp. 113-115
Author(s):  
Nitesh R. Maurya ◽  
◽  
Urvi C. Bhavsar ◽  
Sushrut A. Bhukte ◽  
Vijayshree S. Patil ◽  
...  

2020 ◽  
Vol 8 (C) ◽  
pp. 94-98
Author(s):  
Goran Borislav Kondov ◽  
Viktor Gruev ◽  
Sinisha Stojanovski ◽  
Magdalena Bogdanovska-Todorovska ◽  
Risto Colanceski ◽  
...  

BACKGROUND: Sentinel lymph node (SNL) biopsy in breast cancer for the determination of axillary status is standard procedures in surgical treatment of early-stage breast cancer. The identification of the SNL is usually performed by radiocolloid injection or/and injection of methylene blue due. The use of indocyanine green (ICG) dye, which is fluorescent dye, which movement in breast and axillar pit, can be followed with special cameras which detect near infrared specatar of light. CASE REPORT: In this paper, we present case report of patient with breast cancer, where we perform SNL detection with three methods: Use of radiocolloid which we trace with static gamma camera, and intraoperatively with hand held gamma probe, methylene blue dye which movement we followed by eye contact and using indocyanine green which movement was followed by specially constructed multispectral camera, which can detect near-infrared fluorescence that is emitted by ICG and methyline blue, respectively. CONCLUSION: Fluorescent imaging with ICG is a sensitive, valuable, and safe method for SNL biopsy. Finding new agents that would identify the SNL, especially if they are not radioactive would be an important step in wider application of this method.


Sign in / Sign up

Export Citation Format

Share Document